OC-0256 Biomarker development from joint analyses of HNSCC xenografts and patients treated by PORT-C. (May 2022) - Linge, A.; Patil, S.; Gurtner, K.; Grosser, M.; Lohaus, F.; Gudziol, V.; Nowak, A.; Tinhofer, I.; Budach, V.; Guberina, M.; Stuschke, M.; Balermpas, P.; et al.